About
us
Learn more
Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited
International pharmaceutical enterprises of scientific and technological innovation
Grand Pharmaceutical Group Co., Ltd. (stock code: 00512. HK) is a research-based international pharmaceutical enterprise that specialises in pharmaceutical technology, nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology and biotechnology.
9 +

R&D Centers

700 +

R&D People

133 +

Projects in Progress

Global R&D Map
Internationalization
Learn more
Dare to be the first and share the success
Dare to be the first and share the success
In recent years, Grand Pharma has deployed a series of innovative pharmaceutical products with broad market in the United States, Australia, Germany, Belgium and other countries. Our Group has established strong partnerships with the world's leading pharmaceutical companies, universities and research institutes, and achieved a rich and diversified product pipeline in a range of medical therapeutic areas. Our Group has already invested and operated 5 R&D technology platforms and 9 R&D centers worldwide.
Core Business Areas
Respiratory and Severe Disease Anti-infection
Tumor
Cerebro-cardiovascular Emergency
Ophthalmology
Nuclear Medicine Anti-tumor Diagnosis and Treatment
Cerebro-cardiovascular Precision Interventional Diagnosis and Treatment
High-quality Amino Acids

Pharmaceutical Technology

Nuclear Medicine Anti tumor Diagnosis and Treatment & Cerebro cardiovascular Precision Interventional Diagnosis and Treatment

Biotechnology